About Index Trending news
Lists
Pricing
Mersana Therapeutics

Mersana Therapeutics

Mersana Therapeutics

Rewriting the rules for immunoconjugate therapies.

Elsewhere

Contributors to this profile

Alexa global traffic share

Twitter followers

16 Jun 2016
$33,000,000
Venture capital (Series C)

Booming Mersana Nabs Another 33 Million for a Total Take of 120 Million

biospace
+1